RMS LifeRisks: Alzheimer's Disease Treatments as Longevity Catalysts

The resilience and longevity of the elderly depends crucially on cognitive functioning, psychological well-being and social functioning. All three of these are eroded by Alzheimer's disease. A large proportion of non-COVID-19 excess deaths are Alzheimer's sufferers, who lacked the resilience to cope. Join Gordon Woo from RMS to explore the research horizon for Alzheimer's treatments, and their potential as longevity catalysts.

Panelist:

Dr. Gordon Woo, RMS Catastrophist